SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
Q3’07
Earnings Call
           November 6, 2007
Forward-Looking Statements
Certain statements contained in this presentation constitute forward-looking statements. Such forward-looking statements are based on
management's current expectations and involve known and unknown risks, uncertainties and other factors that may cause the
Company’s actual results to be materially different from those expressed or implied by such forward-looking statements. Such factors
include, among others, the following: general economic and business conditions, both nationally and regionally; industry capacity;
demographic changes; changes in, or the failure to comply with, laws and governmental regulations; the ability to enter into managed
care provider arrangements on acceptable terms; changes in Medicare and Medicaid payments or reimbursement, including those
resulting from a shift from traditional reimbursement to managed care plans; liability and other claims asserted against the Company;
competition, including the Company’s failure to attract patients to its hospitals; the loss of any significant customers; technological and
pharmaceutical improvements that increase the cost of providing, or reduce the demand for, health care; a shortage of raw materials, a
breakdown in the distribution process or other factors that may increase the Company’s cost of supplies; changes in business strategy
or development plans; the ability to attract and retain qualified personnel, including physicians, nurses and other health care
professionals, including the impact on the Company’s labor expenses resulting from a shortage of nurses or other health care
professionals; the significant indebtedness of the Company; the availability of suitable acquisition opportunities and the length of time it
takes to accomplish acquisitions; the Company's ability to integrate new businesses with its existing operations; and the availability and
terms of capital to fund the expansion of the Company's business, including the acquisition of additional facilities. Certain additional
risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s
annual report on Form 10-K and quarterly reports on Form 10-Q. Do not rely on any forward-looking statement, as we cannot predict or
control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any
forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.



Non-GAAP Information
During the earnings call and in this presentation, management will be referring to certain financial measures and statistics, including
measures such as adjusted EBITDA, which are not calculated in accordance with Generally Accepted Accounting Principles (GAAP).
Management recommends that you focus on the GAAP numbers as the best indicator of financial performance. These alternative
measures are provided only as a supplement to aid in analysis of the Company.
Reconciliation between non-GAAP measures and related GAAP measures can be found in the press release issued this morning,
November 6, 2007, and on the Company’s web site, www.tenethealth.com.




                                                                                                                                               2
Trevor Fetter
President and CEO
Key trends moving in the right direction
            0.8% admissions decline (same-hospital) versus 2.2 % decline in Q2’07
            (as reported)
 Volumes
            0.1% admissions increase, excluding Florida and USC (same-hospital)
            0.6% commercial managed care admissions decline (same-hospital)
            0.4% commercial managed care admissions increase (same-hospital),
            excluding USC and Florida
            1.4% outpatient visits decline (same-hospital)
            1.0% October 2007 admissions increase despite tough 1.2% Oct’06 comp
            (as reported)

 Adjusted   $177mm – 55% increase versus Q3’06 (same-hospital increase in 54%)
 EBITDA
            7.9 % increase from Q2’07 despite Q3 seasonal pressures

 Pricing    6.8 % increase in net revenue per adjusted admission (same-hospital)
            7.4 % increase in net revenue per adjusted patient day (same-hospital)

 Revenue    7.0 % increase in net operating revenue (same-hospital)


                                                                                     4
Key trends moving in the right direction
(Continued)

              4.2% growth in controllable operating expense per adjusted patient day
 Costs        (same-hospital)



Bad Debt
              7.2% of revenues – flat to Q3’06
              36% self-pay collection rate versus 30% in Q3’06


              93.7% CMS Hospital Compare metric in Q2’07 highest to date
Quality
              92.5% for four quarters ended Q2’07




                                                                                       5
Focus on Quality has Positioned Us Well
                         CMS Hospital Compare Data*
     95%
                                                                                                                                                               92.5%
     93%                                                                                                                                           91.7%
                                                                                                                               90.4%
     91%
                                                                                                           89.1%
                                                                                               88.3%
     89%
                                                                                 86.7%                                                     87.5%
     87%                                                                                                               86.7%

     85%                                                            83.8%                      85.9%
                                                       82.6%                       84.7%
     83%                                81.5%
                                                                     83.3%
            80.2%        80.5%                           82.3%
     81%
                                               80.9%
     79%                        79.4%
                                                                                                                                  Tenet
     77%     77.9%                                                                                                                National Average
     75%
             Q104-Q404


                          Q204-Q105


                                         Q304-Q205


                                                        Q404-Q305


                                                                     Q105-Q405


                                                                                   Q205-Q106


                                                                                               Q305-Q206


                                                                                                           Q405-Q306


                                                                                                                               Q106-Q406


                                                                                                                                                   Q206-Q107


                                                                                                                                                                Q306-Q207
                                                                    Trailing Four Quarters


           * Includes AMI/HF/PN measures only. Data is for 55 hospitals.
                                                                                                                                                                            6
Q3 2007 Summary

 • Q3’07 adjusted EBITDA exceeds Q2’07, despite typical
   seasonal pressures
 • Breadth of factors supported this performance
   – Commercial volume growth outside USC and Florida
   – Pricing enhancements
   – Cost control
 • October 2007 admissions increased 1.0%




         Note: For reconciliation of net loss to adjusted EBITDA see table #1 in our Q3’07 earnings release.


                                                                                                               7
Stephen L. Newman, M.D.
    Chief Operating Officer
Selected key elements of turnaround
strategy
  1. Effective cost management
  2. Targeted Growth Initiative producing volumes
     increases in commercial managed care
  3. Growing active physician staff
  4. Florida’s fresh initiatives
  5. Turnaround success stories



                                                    9
Cost management accelerated in Q3

   Reduced FTEs by 1,275       (year-over-year)

      2.7% reduction in FTEs outpaces 0.8% admissions decline
   208 FTE decline from corporate and regional support
      7.5% of overhead jobs
   4.2% growth in controllable operating expenses (same-hospital)
   2.6% increase in supply costs per adjusted patient day (same-hospital)
      Supply costs declined to 17.3 % of net revenues

      80 basis point decline



                                                                            10
Commercial managed care volumes grew
in service lines targeted by TGI

 Phase One TGI completed in 52 hospitals
 Phase Two TGI currently being implemented
 Targeted service lines evidence commercial
 volume growth (1)
   12.7% increase in commercial neonatal services
    5.5% increase in commercial oncological surgery
   admissions
    5.4% increase in commercial open heart surgeries

         (1) All growth rates are same-hospital Q3’07 versus Q3’06

                                                                     11
Physician Relationships: Recruiting,
redirecting, relocating, and hiring more
doctors
 370 net new physicians added in Q3’07 with active staff privileges (1)
      3.4% net increase in just Q3’07
      7.7% net increase Y-T-D September 30, 2007
      35 newly employed physicians included in Q3’07
 270 – target for newly employed physicians by year-end 2010
      590 total target for employed physicians, year-end 2010
 5,900+ physician visits in Physician Relationship Program (PRP) in Q3’07
      60% increase in physician visits as compared to 3,700 visits in Q3’06
      930 of the Q3’07 visits were 1st time visits to existing staff physicians
      419 of the Q3’07 visits were 1st time visits to new physicians



(1) “Active staff” status generally requires at least 10 admissions per year or 10 outpatient surgeries per year.


                                                                                                                    12
Florida implementing fresh initiatives

 1. Marsha Powers hired to run Florida
 2. Consolidated Palm Beach and Miami markets
      Coordinate and leverage business development
      Capture economies of scale
 3. Reduced patient out-migration
 4. Adding new physicians to our Florida medical staffs
 5. Accelerated cost reduction efforts
      North Ridge Medical Center to be divested
 6. New managed care contracts
      Eliminate out-of-network situations
      Volume guarantees




                                                          13
Turnaround Success Stories
 Philadelphia market
   3.3% increase in Q3’07 admissions


 North Shore Medical Center – Miami
   5.8% increase in Q3’07 admissions


 Atlanta Medical Center
   8.5% increase in Q3’07 admissions


 Houston Northwest Medical Center
   8.4% admission growth in Q3’07


                                       14
Compelling, tangible evidence of progress

 Solid cost control
 TGI producing growth in targeted commercial
 managed care volumes
 Adding physicians to active medical staffs
 Signs of progress in Florida
 Growing number of hospital success stories




                                               15
Biggs C. Porter
Chief Financial Officer
Volume – Commercial Managed Care
         Admissions
                  Same Hospital Growth
  2%



  0%
        Q1   Q2          Q3   Q4   Q1    Q2     Q3


  -2%



  -4%



  -6%
                  2006                   2007




                                                     17
Volume - Admissions
                  Same Hospital Growth
  2%




  0%
       Q1   Q2          Q3   Q4   Q1     Q2     Q3



 -2%




                 2006                    2007
 -4%




                                                     18
Volume - Outpatient Visits

                   Same Hospital Growth
   1%


  -1%   Q1   Q2          Q3   Q4   Q1     Q2     Q3


  -3%


  -5%


  -7%


  -9%             2006                    2007




                                                      19
Net Revenue

                    Same Hospital Growth
  8%

  6%


  4%


  2%


  0%
        Q1   Q2          Q3   Q4   Q1      Q2   Q3
  -2%
                  2006                  2007

  -4%




                                                     20
Solid pricing gains
7.8% increase in net inpatient revenue per admission
9.7% increase in net outpatient revenue per visit
Recently signed contracts supported pricing growth
$32 million favorable swing in Q3’07 cost report
adjustments versus Q3’06
ED scoring and charge increases contributed further
support
Additional commercial contracts expected in Q4’07 should
help extend gains in 2008
Medicaid funding in Florida and Georgia expected to have a
$60 million adverse impact in 2008


                                                             21
Cost Containment
                   Growth in Controllable Expenses(1)
                      per Equivalent Patient Day
  8%

                                                                      6.5%
                                                      6.3%

  6%
       5.1%
                                                                                       4.8%
                     4.3%                                                                              4.2%
  4%                                  3.6%




  2%



  0%
        Q1              Q2              Q3              Q4              Q1               Q2              Q3

                              2006                                                     2007
       (1) Total controllable expenses defined as SWB, supplies, and other operating expenses. Same-hospitals excluding Coastal
               Carolina.
                                                                                                                                  22
Non-volume Variables (1)
     ($ in millions)
                                                                          2007             Annualized
  Core/Planned Cost Reductions                                             $50               $65 - $85


  Other Upside Initiatives:                                              $30 +                   $60 +
   Staffing Reductions
   DRG Documentation
   ED Scoring
   CDM Reviews
   Denials Management
   Bad Debt Initiatives
   Improved Costing of Medical Devices
   Reduce Consulting & Overhead Spend
   Reduced Turnover

          (1) These items disclosed as above on June 5, 2007. Items are updated and expanded to add Q4’07 and increased
          annualized impact on next page.
                                                                                                                          23
Non-volume Variables
            ($ in millions)

                                          Prior Estimate           Actual         Current Estimate

                                       2007     Annualized    YTD       Q3’07    Q4’07   Annualized

Core/Planned Cost Reductions           $50        $65 - $85   43            19   11          95



Other Upside Initiatives:              $30 +       $60 +      36            20   37          150

 Staffing Reductions

 DRG Documentation

 ED Scoring

 CDM Reviews

 Denials Management

 Bad Debt Initiatives

 Improved Costing of Medical Devices

 Reduce Consulting & Overhead Spend

 Reduced Turnover




                                                                                                     24
Bad Debt
          Bad Debt Expense / Net Revenues (%)
    18%                         (excluding unusual charges)

    16%

    14%

    12%

    10%

     8%

     6%

     4%

     2%
                                                                                      As reported

     0%
                                                                                      Compact-adjusted (1)
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
          Q4
          Q1
          Q2
          Q3
                                                                                      (as reported)



            2000     2001      2002      2003       2004       2005     2006   2007


      (1) Compact adjustment calculations discontinued beginning in Q1’07.

                                                                                                             25
Tenet’s Collection Rates . . . .
    Have Strengthened in Recent Quarters

       100%
                   98% - Managed Care (Q2’07’; Q3’07)
                     97% - Managed Care (Q1’07)




                                        64% - Balance-After (Q2’07; Q3’07)
Collection                                60% - Balance-After (Q1’07)
  Rate
                                                    36% - Blended “Self Pay” (Q3’07)
                                                     35% - Blended “Self Pay” (Q2’07)
                                                       33% - Blended “Self Pay” (Q1’07)




                                                                       12%-Uninsured (current)
                                                                       8%-Uninsured (pre-Compact)
         0%                                                            0%-Charity Care
              Fully Insured                                        Uninsured


                                 Degree of Insurance


                                                                                                 26
Significantly Reducing “Days to Collection”
Across our hospitals, A/R days Managed Care and Medicare aging
are all down, releasing significant incremental cash.
                                                     Managed Care
                                                     Managed Care                                              Medicare A/R
                                                                                                               Medicare A/R
          A/R Days1
          A/R Days1                                 A/R Greater than
                                                    A/R Greater than                                          Greater than 60
                                                                                                              Greater than 60
                                                       180 days2
                                                       180 days2                                                  days2
                                                                                                                   days2

                             Q3                                                      Q3                                                Q3
2003   2004   2005   2006                2003       2004       2005      2006                     2003       2004      2005   2006
                            2007                                                    2007                                              2007


73.9   56.3   57.8   55.1   53.4          N/A      $482M $357M $324M $289M                        $63M      $40M       $28M   $13M    $20M




         Overall                                             Reduced                                                Reduced
        reduction                                             MC A/R                                                MCR A/R
          of 20.5                                            by $193M                                               by $43M
         days or                                              or 40%                                                 or 68%
           28%




                            1 Same store hospital only core acute facilities with prior year cost settlement for all years
                            2 Same store hospital only core acute facilities plus Rio and Pinecrest Rehab excluding Plaza Specialty,
                              Coastal Carolina, Centennial, Bartlett and Norris Cancer Center for all years; 2003 Managed care data not
                              available – no detail at that level in 2003                                                                 27
Revenue Cycle Initiatives…
      Have Led to Improved Collections

• Accelerate communication of patient’s personal
  responsibility for payment
• Request payment at point of service
• Simplify bills to improve patient understanding
• Provide financial credit to patients from a 3rd
  party in a pilot program



                                                    28
Cash Flow
Capex was $179mm
Adjusted operating cash flow
  $82mm YTD
  $93mm in Q3’07
Q3’07 cash flow impacted by:
  $14mm insurance premiums (do not recur in Q4’07)
  $12mm receipt from Philadelphia HMO sale
  $123mm in interest payments
     Compared to $82mm in Q4’07
  $43mm net favorable impact from above 3 items Q4’07 compared to
  Q3’07
Additional working capital initiatives expected to impact Q4’07


                                                                    29
2007 Cash Walk Forward
($ in millions)
          Beginning Cash (September 30, 2007)           655

          Income Tax Payments                            (8)

          Sale of Facilities and Property                13
          Acquisition Activity                          (11)
          Remaining Interest, net                       (72)

          DOJ Principal Payment                         (24)

          Working Capital Including                  120 - 150
              – AP build-up and terms
              – Normal accruals
              – A/R days reduction
          EBITDA (Q4’07)                             140 - 190

          Stock Compensation Expense & Other           2 -12

          CapEx     (Q4’07)                         (285) – (235)

          Ending Cash         (December 31, 2007)    530 - 670

                                                                    30
Capital Expenditures Per Bed




                                                                                 $54,249




                                                                                                                                       $48,055




                                                                                                                                                      $46,515
                                                                                                                                      $45,876
                                                                                                                 $45,423
                                        $44,217




                                                                                                                            $42,695
  $42,298
              $42,966




                              $41,627




                                                                                                                                                                 $41,528
                                                                                                                                                                              Tenet’s 3-year
                                                                                                                                                                             Tenet’s 3-year
            $38,652




                                                                                                                                                                            ’05-’07 average is




                                                                                                       $37,993
                                                  $36,722                                                                                                                  ’05-’07 average is




                                                                                             $35,373
                                                                       $36,026
                                                             $34,279
                                                                                                                                                                             $41,528 per bed
                                                                                                                                                                            $41,528 per bed




                                                                                                                                                                                    Tenet
                                                                                                                                                                                    HCA
                                                                                                                                                                                    Triad

                                                                                                                                                                  Tenet’s




                                                                                                                                                     t.
  02




                             03




                                                             04




                                                                                              05




                                                                                                                            06

                                                                                                                                                                3-year Avg.


                                                                                                                                                  es
 20




                          20




                                                            20




                                                                                           20




                                                                                                                           20



                                                                                                                                                                  ’05-’07
                                                                                                                                                 07
                                                                                                                                             20



                        * 55 core hospitals from 2002 – 2007.
                        * 2007 capex estimate of $700mm (middle of range of $675 - $725mm) includes approximately $150 million carried over from
                        prior 2006 commitment of $800 million.
                                                                                                                                                                                                 31
2007 Outlook (1)
                                                      Actual                                          Outlook
($ millions)                                YTD                  Q3’07                    Q4’07                           2007
                                           9/30/07
Revenue (Growth %) (2)                         4.0                  7.0                   3.0 – 4.0                     3.5 – 4.5
Admissions (Growth %) (2)                     (1.4)                (0.8)               (0.5) – 0.5                    (1.2) – (0.9)

Outpatient visits (Growth %) (2)              (2.1)                (1.4)                   0 – 1.0                    (1.6) – (1.4)
Adjusted EBITDA (3)                            535                  177                  140 – 190                      675 – 725
Pretax Income (Loss) (3)                      (16)                  (9)                  (58) – (8)                    (75) – (25)

Net Loss (4)                                  (14)                  (14)                 (52) – (2)                    (66) – (16)

EPS (4)                                      (0.02)               (0.03)              (0.08) – (0.01)                (0.10) – (0.03)

Cash from Ops (3)                              82                    93                  198 – 278                      280 – 360
Capital Spending                               440                  179                  235 – 285                      675 – 725
Cash (Period End)                              655                  655                  530 – 670                      530 – 670
               (1) In $ millions, except per share amounts.
               (2) Same hospital.
               (3) Adjusted EBITDA excludes charges/payments for impairment, restructuring and litigation.
               (4) Excludes the change in the federal income tax valuation allowance and first quarter 2007 FIN 48 tax gain and assumes a
                   normalized tax rate of 37.5%.

               Note: For reconciliation of net loss to adjusted EBITDA see table #3 in our third quarter earnings release.
                                                                                                                                            32
Summary


 Results could be bumpy but positive trends
 developing
 Progress on volumes, pricing and costs
 Focused on cash and return on invested capital
 Bad debt expense increase mitigated by
 aggressive offsetting actions



                                                  33
Appendix:
Reconciliation of 2007 Outlook net loss to adjusted
EBITDA
            ($ in millions)                                                                  Low                     High

 Net loss                                                                                    $(76)                   $(26)

 Less: Loss from discontinued operations, net of tax (1)                                      (51)                    (51)

     Income (Loss) from continuing operations                                                 (25)                     25

  Income tax benefit (2)                                                                       75                      75
     Loss from continuing operations, before income taxes                                    (100)                    (50)
  Interest expense, net                                                                      (380)                   (380)
     Operating income                                                                         280                     330
  Litigation benefit (1)                                                                      (1)                      (1)
   Impairment of long-lived assets and goodwill and restructuring                             (24)                    (24)
 charges (1)
  Depreciation and amortization                                                              (370)                   (370)
 Adjusted EBITDA                                                                             $675                    $725

              (1) Represents the loss from discontinued operations for the nine months ended September 30, 2007, litigation and related
                       costs and impairment and restructuring charges. Management is not providing a forecast of these items for the
                       remainder of 2007.
              (2) Includes a favorable income tax adjustment of $93 million in Q1 2007, required under the new FASB pronouncement FIN 48.


                                                                                                                                            34
2009 EBITDA Walk-Forward - - Assumptions (1)

                                                                                                   ($mm)
         Walk-forward starting point                                                                 700
         Price and cost inflation/market adjustment                                               140 -145
         Length of stay reduction                                                                  15 – 30
         Hospital/function-specific productivity                                                     100
         Other upside initiatives (2)                                                                30+
         1.5% annual volume growth from 2007 base (3)                                                105
         Provision for risk                                                                       (0 –100)
         Implied EBITDA range in 2009 (rounded)                                               1,000 – 1,100
         Risks and opportunities currently projected to be realized:

           Georgia and Florida Medicaid (4)                                                          (60)



      (1) Walk-forward to $1.0 to $1.1 billion is as discussed on second quarter conference call (8/6/07). Planning cycle for 2008 is
      currently in progress and Outlook is expected to be provided during the year end conference call in late February 2008.
      (2) Reflects the continuation of 2007 upside initiatives.
      (3) Assumes variable margin of 40% on increased volume in adjusted admissions
      (4) Represents significant identified changes absorbing the zero to $100 million provision for risk allowed for in the walk-forward
      above. There are other risks and opportunities which will be considered in 2008 planning, and which are expected to be net favorable.

                                                                                                                                         35
      NOTE: Refer to Tenet’s 2006 Form 10-K for other risk factors

Weitere ähnliche Inhalte

Ähnlich wie tenet healthcare Q_2007_Q3_Conference_Call_Final

tenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationtenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationfinance42
 
tenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationtenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationfinance42
 
ApresentaçãO 3 Q08 Ingles Final
ApresentaçãO 3 Q08 Ingles FinalApresentaçãO 3 Q08 Ingles Final
ApresentaçãO 3 Q08 Ingles FinalBRMALLS
 
ApresentaçãO 4 Q08 Eng
ApresentaçãO 4 Q08 EngApresentaçãO 4 Q08 Eng
ApresentaçãO 4 Q08 EngBRMALLS
 
04_Fetter_Final
04_Fetter_Final04_Fetter_Final
04_Fetter_Finalfinance42
 
Teleconference 4Q08
Teleconference 4Q08Teleconference 4Q08
Teleconference 4Q08BRMALLS
 
unum group Updated_Citigroup
unum group   Updated_Citigroupunum group   Updated_Citigroup
unum group Updated_Citigroupfinance26
 
unum group Updated_Citigroup
unum group   Updated_Citigroupunum group   Updated_Citigroup
unum group Updated_Citigroupfinance26
 
Presentation: Health Reform in Massachusetts
Presentation: Health Reform in MassachusettsPresentation: Health Reform in Massachusetts
Presentation: Health Reform in Massachusettsmasscare
 
Citi´s 1st Annual Brazil Equity Conference*
Citi´s 1st Annual Brazil Equity Conference*Citi´s 1st Annual Brazil Equity Conference*
Citi´s 1st Annual Brazil Equity Conference*CPFL RI
 
Apresentacao 2 Q09 Ing
Apresentacao 2 Q09 IngApresentacao 2 Q09 Ing
Apresentacao 2 Q09 IngBRMALLS
 
WHS Report Card 2010-2011
WHS Report Card 2010-2011WHS Report Card 2010-2011
WHS Report Card 2010-2011JD Williamson
 
4 q07 financial and operating results presentation
4 q07 financial and operating results presentation4 q07 financial and operating results presentation
4 q07 financial and operating results presentationEquatorial
 
4 q07 financial and operating results presentation
4 q07 financial and operating results presentation4 q07 financial and operating results presentation
4 q07 financial and operating results presentationEquatorial
 
11/13/2007 - 3Q07 Earnings Call Presentation
11/13/2007  	-   	3Q07 Earnings Call Presentation11/13/2007  	-   	3Q07 Earnings Call Presentation
11/13/2007 - 3Q07 Earnings Call PresentationAES Tietê
 
2010 Edelman Trust Barometer - Indonesia
2010 Edelman Trust Barometer - Indonesia2010 Edelman Trust Barometer - Indonesia
2010 Edelman Trust Barometer - IndonesiaEdelman Digital
 
16_Hailey_ManagedCare_Final
16_Hailey_ManagedCare_Final16_Hailey_ManagedCare_Final
16_Hailey_ManagedCare_Finalfinance42
 

Ähnlich wie tenet healthcare Q_2007_Q3_Conference_Call_Final (20)

tenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationtenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentation
 
tenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentationtenet healthcare QuarterEndedDecember312008PowerPointPresentation
tenet healthcare QuarterEndedDecember312008PowerPointPresentation
 
ApresentaçãO 3 Q08 Ingles Final
ApresentaçãO 3 Q08 Ingles FinalApresentaçãO 3 Q08 Ingles Final
ApresentaçãO 3 Q08 Ingles Final
 
ApresentaçãO 4 Q08 Eng
ApresentaçãO 4 Q08 EngApresentaçãO 4 Q08 Eng
ApresentaçãO 4 Q08 Eng
 
04_Fetter_Final
04_Fetter_Final04_Fetter_Final
04_Fetter_Final
 
Teleconference 4Q08
Teleconference 4Q08Teleconference 4Q08
Teleconference 4Q08
 
unum group Updated_Citigroup
unum group   Updated_Citigroupunum group   Updated_Citigroup
unum group Updated_Citigroup
 
unum group Updated_Citigroup
unum group   Updated_Citigroupunum group   Updated_Citigroup
unum group Updated_Citigroup
 
Presentation: Health Reform in Massachusetts
Presentation: Health Reform in MassachusettsPresentation: Health Reform in Massachusetts
Presentation: Health Reform in Massachusetts
 
Citi´s 1st Annual Brazil Equity Conference*
Citi´s 1st Annual Brazil Equity Conference*Citi´s 1st Annual Brazil Equity Conference*
Citi´s 1st Annual Brazil Equity Conference*
 
3Q_2008_NR
3Q_2008_NR3Q_2008_NR
3Q_2008_NR
 
3Q12 Presentation
3Q12 Presentation3Q12 Presentation
3Q12 Presentation
 
Apresentacao 2 Q09 Ing
Apresentacao 2 Q09 IngApresentacao 2 Q09 Ing
Apresentacao 2 Q09 Ing
 
avy-NR
avy-NRavy-NR
avy-NR
 
WHS Report Card 2010-2011
WHS Report Card 2010-2011WHS Report Card 2010-2011
WHS Report Card 2010-2011
 
4 q07 financial and operating results presentation
4 q07 financial and operating results presentation4 q07 financial and operating results presentation
4 q07 financial and operating results presentation
 
4 q07 financial and operating results presentation
4 q07 financial and operating results presentation4 q07 financial and operating results presentation
4 q07 financial and operating results presentation
 
11/13/2007 - 3Q07 Earnings Call Presentation
11/13/2007  	-   	3Q07 Earnings Call Presentation11/13/2007  	-   	3Q07 Earnings Call Presentation
11/13/2007 - 3Q07 Earnings Call Presentation
 
2010 Edelman Trust Barometer - Indonesia
2010 Edelman Trust Barometer - Indonesia2010 Edelman Trust Barometer - Indonesia
2010 Edelman Trust Barometer - Indonesia
 
16_Hailey_ManagedCare_Final
16_Hailey_ManagedCare_Final16_Hailey_ManagedCare_Final
16_Hailey_ManagedCare_Final
 

Mehr von finance42

saic annual reports 2003
saic annual reports 2003saic annual reports 2003
saic annual reports 2003finance42
 
saic annual reports 2004
saic annual reports 2004saic annual reports 2004
saic annual reports 2004finance42
 
saic annual reports 2005
saic annual reports 2005saic annual reports 2005
saic annual reports 2005finance42
 
saic annual reports 2006
saic annual reports 2006saic annual reports 2006
saic annual reports 2006finance42
 
saic annual reports 2007
saic annual reports 2007saic annual reports 2007
saic annual reports 2007finance42
 
saic annual reports 2008
saic annual reports 2008saic annual reports 2008
saic annual reports 2008finance42
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808finance42
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808finance42
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808finance42
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808finance42
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008finance42
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508finance42
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508finance42
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conffinance42
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008finance42
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conffinance42
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508finance42
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508finance42
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508finance42
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508finance42
 

Mehr von finance42 (20)

saic annual reports 2003
saic annual reports 2003saic annual reports 2003
saic annual reports 2003
 
saic annual reports 2004
saic annual reports 2004saic annual reports 2004
saic annual reports 2004
 
saic annual reports 2005
saic annual reports 2005saic annual reports 2005
saic annual reports 2005
 
saic annual reports 2006
saic annual reports 2006saic annual reports 2006
saic annual reports 2006
 
saic annual reports 2007
saic annual reports 2007saic annual reports 2007
saic annual reports 2007
 
saic annual reports 2008
saic annual reports 2008saic annual reports 2008
saic annual reports 2008
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
 
terex Merrill050808
terex Merrill050808terex Merrill050808
terex Merrill050808
 
terex BofA050808
terex BofA050808terex BofA050808
terex BofA050808
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
 
terex Shareholders0508
terex Shareholders0508terex Shareholders0508
terex Shareholders0508
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
 
terex Sanford053008
terex Sanford053008terex Sanford053008
terex Sanford053008
 
terex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Confterex 08_06_04_JP_Morgan_Conf
terex 08_06_04_JP_Morgan_Conf
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
 
terex Wachovia062508
terex Wachovia062508terex Wachovia062508
terex Wachovia062508
 

Kürzlich hochgeladen

20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdfAdnet Communications
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...mwangimwangi222
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Guillaume Ⓥ Sarlat
 
MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.Arifa Saeed
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfMichael Silva
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?Stephen Perrenod
 
The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...Antonis Zairis
 
Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Commonwealth
 
2024.03 Strategic Resources Presentation
2024.03 Strategic Resources Presentation2024.03 Strategic Resources Presentation
2024.03 Strategic Resources PresentationAdnet Communications
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfAdnet Communications
 
Stock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfStock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfMichael Silva
 
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxSlideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxOffice for National Statistics
 
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...Matthews Bantsijang
 
20240315 _E-Invoicing Digiteal. .pptx
20240315 _E-Invoicing Digiteal.    .pptx20240315 _E-Invoicing Digiteal.    .pptx
20240315 _E-Invoicing Digiteal. .pptxFinTech Belgium
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxsonamyadav7097
 
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an EntrepreneurIntroduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an Entrepreneurabcisahunter
 
What Key Factors Should Risk Officers Consider When Using Generative AI
What Key Factors Should Risk Officers Consider When Using Generative AIWhat Key Factors Should Risk Officers Consider When Using Generative AI
What Key Factors Should Risk Officers Consider When Using Generative AI360factors
 

Kürzlich hochgeladen (20)

20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024
 
MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdf
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?
 
The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...The unequal battle of inflation and the appropriate sustainable solution | Eu...
The unequal battle of inflation and the appropriate sustainable solution | Eu...
 
Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]Monthly Market Risk Update: March 2024 [SlideShare]
Monthly Market Risk Update: March 2024 [SlideShare]
 
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
New Monthly Enterprises Survey. Issue 21. (01.2024) Ukrainian Business in War...
 
2024.03 Strategic Resources Presentation
2024.03 Strategic Resources Presentation2024.03 Strategic Resources Presentation
2024.03 Strategic Resources Presentation
 
Commercial Bank Economic Capsule - March 2024
Commercial Bank Economic Capsule - March 2024Commercial Bank Economic Capsule - March 2024
Commercial Bank Economic Capsule - March 2024
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
 
Stock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdfStock Market Brief Deck for 3/22/2024.pdf
Stock Market Brief Deck for 3/22/2024.pdf
 
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptxSlideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
Slideshare - ONS Economic Forum Slidepack - 18 March 2024.pptx
 
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...
Remembering my Totem _Unity is Strength_ growing in Bophuthatswana_Matthews B...
 
20240315 _E-Invoicing Digiteal. .pptx
20240315 _E-Invoicing Digiteal.    .pptx20240315 _E-Invoicing Digiteal.    .pptx
20240315 _E-Invoicing Digiteal. .pptx
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptx
 
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an EntrepreneurIntroduction to Entrepreneurship and Characteristics of an Entrepreneur
Introduction to Entrepreneurship and Characteristics of an Entrepreneur
 
What Key Factors Should Risk Officers Consider When Using Generative AI
What Key Factors Should Risk Officers Consider When Using Generative AIWhat Key Factors Should Risk Officers Consider When Using Generative AI
What Key Factors Should Risk Officers Consider When Using Generative AI
 
Monthly Economic Monitoring of Ukraine No.230, March 2024
Monthly Economic Monitoring of Ukraine No.230, March 2024Monthly Economic Monitoring of Ukraine No.230, March 2024
Monthly Economic Monitoring of Ukraine No.230, March 2024
 

tenet healthcare Q_2007_Q3_Conference_Call_Final

  • 1. Q3’07 Earnings Call November 6, 2007
  • 2. Forward-Looking Statements Certain statements contained in this presentation constitute forward-looking statements. Such forward-looking statements are based on management's current expectations and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from those expressed or implied by such forward-looking statements. Such factors include, among others, the following: general economic and business conditions, both nationally and regionally; industry capacity; demographic changes; changes in, or the failure to comply with, laws and governmental regulations; the ability to enter into managed care provider arrangements on acceptable terms; changes in Medicare and Medicaid payments or reimbursement, including those resulting from a shift from traditional reimbursement to managed care plans; liability and other claims asserted against the Company; competition, including the Company’s failure to attract patients to its hospitals; the loss of any significant customers; technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for, health care; a shortage of raw materials, a breakdown in the distribution process or other factors that may increase the Company’s cost of supplies; changes in business strategy or development plans; the ability to attract and retain qualified personnel, including physicians, nurses and other health care professionals, including the impact on the Company’s labor expenses resulting from a shortage of nurses or other health care professionals; the significant indebtedness of the Company; the availability of suitable acquisition opportunities and the length of time it takes to accomplish acquisitions; the Company's ability to integrate new businesses with its existing operations; and the availability and terms of capital to fund the expansion of the Company's business, including the acquisition of additional facilities. Certain additional risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise. Non-GAAP Information During the earnings call and in this presentation, management will be referring to certain financial measures and statistics, including measures such as adjusted EBITDA, which are not calculated in accordance with Generally Accepted Accounting Principles (GAAP). Management recommends that you focus on the GAAP numbers as the best indicator of financial performance. These alternative measures are provided only as a supplement to aid in analysis of the Company. Reconciliation between non-GAAP measures and related GAAP measures can be found in the press release issued this morning, November 6, 2007, and on the Company’s web site, www.tenethealth.com. 2
  • 4. Key trends moving in the right direction 0.8% admissions decline (same-hospital) versus 2.2 % decline in Q2’07 (as reported) Volumes 0.1% admissions increase, excluding Florida and USC (same-hospital) 0.6% commercial managed care admissions decline (same-hospital) 0.4% commercial managed care admissions increase (same-hospital), excluding USC and Florida 1.4% outpatient visits decline (same-hospital) 1.0% October 2007 admissions increase despite tough 1.2% Oct’06 comp (as reported) Adjusted $177mm – 55% increase versus Q3’06 (same-hospital increase in 54%) EBITDA 7.9 % increase from Q2’07 despite Q3 seasonal pressures Pricing 6.8 % increase in net revenue per adjusted admission (same-hospital) 7.4 % increase in net revenue per adjusted patient day (same-hospital) Revenue 7.0 % increase in net operating revenue (same-hospital) 4
  • 5. Key trends moving in the right direction (Continued) 4.2% growth in controllable operating expense per adjusted patient day Costs (same-hospital) Bad Debt 7.2% of revenues – flat to Q3’06 36% self-pay collection rate versus 30% in Q3’06 93.7% CMS Hospital Compare metric in Q2’07 highest to date Quality 92.5% for four quarters ended Q2’07 5
  • 6. Focus on Quality has Positioned Us Well CMS Hospital Compare Data* 95% 92.5% 93% 91.7% 90.4% 91% 89.1% 88.3% 89% 86.7% 87.5% 87% 86.7% 85% 83.8% 85.9% 82.6% 84.7% 83% 81.5% 83.3% 80.2% 80.5% 82.3% 81% 80.9% 79% 79.4% Tenet 77% 77.9% National Average 75% Q104-Q404 Q204-Q105 Q304-Q205 Q404-Q305 Q105-Q405 Q205-Q106 Q305-Q206 Q405-Q306 Q106-Q406 Q206-Q107 Q306-Q207 Trailing Four Quarters * Includes AMI/HF/PN measures only. Data is for 55 hospitals. 6
  • 7. Q3 2007 Summary • Q3’07 adjusted EBITDA exceeds Q2’07, despite typical seasonal pressures • Breadth of factors supported this performance – Commercial volume growth outside USC and Florida – Pricing enhancements – Cost control • October 2007 admissions increased 1.0% Note: For reconciliation of net loss to adjusted EBITDA see table #1 in our Q3’07 earnings release. 7
  • 8. Stephen L. Newman, M.D. Chief Operating Officer
  • 9. Selected key elements of turnaround strategy 1. Effective cost management 2. Targeted Growth Initiative producing volumes increases in commercial managed care 3. Growing active physician staff 4. Florida’s fresh initiatives 5. Turnaround success stories 9
  • 10. Cost management accelerated in Q3 Reduced FTEs by 1,275 (year-over-year) 2.7% reduction in FTEs outpaces 0.8% admissions decline 208 FTE decline from corporate and regional support 7.5% of overhead jobs 4.2% growth in controllable operating expenses (same-hospital) 2.6% increase in supply costs per adjusted patient day (same-hospital) Supply costs declined to 17.3 % of net revenues 80 basis point decline 10
  • 11. Commercial managed care volumes grew in service lines targeted by TGI Phase One TGI completed in 52 hospitals Phase Two TGI currently being implemented Targeted service lines evidence commercial volume growth (1) 12.7% increase in commercial neonatal services 5.5% increase in commercial oncological surgery admissions 5.4% increase in commercial open heart surgeries (1) All growth rates are same-hospital Q3’07 versus Q3’06 11
  • 12. Physician Relationships: Recruiting, redirecting, relocating, and hiring more doctors 370 net new physicians added in Q3’07 with active staff privileges (1) 3.4% net increase in just Q3’07 7.7% net increase Y-T-D September 30, 2007 35 newly employed physicians included in Q3’07 270 – target for newly employed physicians by year-end 2010 590 total target for employed physicians, year-end 2010 5,900+ physician visits in Physician Relationship Program (PRP) in Q3’07 60% increase in physician visits as compared to 3,700 visits in Q3’06 930 of the Q3’07 visits were 1st time visits to existing staff physicians 419 of the Q3’07 visits were 1st time visits to new physicians (1) “Active staff” status generally requires at least 10 admissions per year or 10 outpatient surgeries per year. 12
  • 13. Florida implementing fresh initiatives 1. Marsha Powers hired to run Florida 2. Consolidated Palm Beach and Miami markets Coordinate and leverage business development Capture economies of scale 3. Reduced patient out-migration 4. Adding new physicians to our Florida medical staffs 5. Accelerated cost reduction efforts North Ridge Medical Center to be divested 6. New managed care contracts Eliminate out-of-network situations Volume guarantees 13
  • 14. Turnaround Success Stories Philadelphia market 3.3% increase in Q3’07 admissions North Shore Medical Center – Miami 5.8% increase in Q3’07 admissions Atlanta Medical Center 8.5% increase in Q3’07 admissions Houston Northwest Medical Center 8.4% admission growth in Q3’07 14
  • 15. Compelling, tangible evidence of progress Solid cost control TGI producing growth in targeted commercial managed care volumes Adding physicians to active medical staffs Signs of progress in Florida Growing number of hospital success stories 15
  • 16. Biggs C. Porter Chief Financial Officer
  • 17. Volume – Commercial Managed Care Admissions Same Hospital Growth 2% 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 -2% -4% -6% 2006 2007 17
  • 18. Volume - Admissions Same Hospital Growth 2% 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 -2% 2006 2007 -4% 18
  • 19. Volume - Outpatient Visits Same Hospital Growth 1% -1% Q1 Q2 Q3 Q4 Q1 Q2 Q3 -3% -5% -7% -9% 2006 2007 19
  • 20. Net Revenue Same Hospital Growth 8% 6% 4% 2% 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 -2% 2006 2007 -4% 20
  • 21. Solid pricing gains 7.8% increase in net inpatient revenue per admission 9.7% increase in net outpatient revenue per visit Recently signed contracts supported pricing growth $32 million favorable swing in Q3’07 cost report adjustments versus Q3’06 ED scoring and charge increases contributed further support Additional commercial contracts expected in Q4’07 should help extend gains in 2008 Medicaid funding in Florida and Georgia expected to have a $60 million adverse impact in 2008 21
  • 22. Cost Containment Growth in Controllable Expenses(1) per Equivalent Patient Day 8% 6.5% 6.3% 6% 5.1% 4.8% 4.3% 4.2% 4% 3.6% 2% 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 2006 2007 (1) Total controllable expenses defined as SWB, supplies, and other operating expenses. Same-hospitals excluding Coastal Carolina. 22
  • 23. Non-volume Variables (1) ($ in millions) 2007 Annualized Core/Planned Cost Reductions $50 $65 - $85 Other Upside Initiatives: $30 + $60 + Staffing Reductions DRG Documentation ED Scoring CDM Reviews Denials Management Bad Debt Initiatives Improved Costing of Medical Devices Reduce Consulting & Overhead Spend Reduced Turnover (1) These items disclosed as above on June 5, 2007. Items are updated and expanded to add Q4’07 and increased annualized impact on next page. 23
  • 24. Non-volume Variables ($ in millions) Prior Estimate Actual Current Estimate 2007 Annualized YTD Q3’07 Q4’07 Annualized Core/Planned Cost Reductions $50 $65 - $85 43 19 11 95 Other Upside Initiatives: $30 + $60 + 36 20 37 150 Staffing Reductions DRG Documentation ED Scoring CDM Reviews Denials Management Bad Debt Initiatives Improved Costing of Medical Devices Reduce Consulting & Overhead Spend Reduced Turnover 24
  • 25. Bad Debt Bad Debt Expense / Net Revenues (%) 18% (excluding unusual charges) 16% 14% 12% 10% 8% 6% 4% 2% As reported 0% Compact-adjusted (1) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 (as reported) 2000 2001 2002 2003 2004 2005 2006 2007 (1) Compact adjustment calculations discontinued beginning in Q1’07. 25
  • 26. Tenet’s Collection Rates . . . . Have Strengthened in Recent Quarters 100% 98% - Managed Care (Q2’07’; Q3’07) 97% - Managed Care (Q1’07) 64% - Balance-After (Q2’07; Q3’07) Collection 60% - Balance-After (Q1’07) Rate 36% - Blended “Self Pay” (Q3’07) 35% - Blended “Self Pay” (Q2’07) 33% - Blended “Self Pay” (Q1’07) 12%-Uninsured (current) 8%-Uninsured (pre-Compact) 0% 0%-Charity Care Fully Insured Uninsured Degree of Insurance 26
  • 27. Significantly Reducing “Days to Collection” Across our hospitals, A/R days Managed Care and Medicare aging are all down, releasing significant incremental cash. Managed Care Managed Care Medicare A/R Medicare A/R A/R Days1 A/R Days1 A/R Greater than A/R Greater than Greater than 60 Greater than 60 180 days2 180 days2 days2 days2 Q3 Q3 Q3 2003 2004 2005 2006 2003 2004 2005 2006 2003 2004 2005 2006 2007 2007 2007 73.9 56.3 57.8 55.1 53.4 N/A $482M $357M $324M $289M $63M $40M $28M $13M $20M Overall Reduced Reduced reduction MC A/R MCR A/R of 20.5 by $193M by $43M days or or 40% or 68% 28% 1 Same store hospital only core acute facilities with prior year cost settlement for all years 2 Same store hospital only core acute facilities plus Rio and Pinecrest Rehab excluding Plaza Specialty, Coastal Carolina, Centennial, Bartlett and Norris Cancer Center for all years; 2003 Managed care data not available – no detail at that level in 2003 27
  • 28. Revenue Cycle Initiatives… Have Led to Improved Collections • Accelerate communication of patient’s personal responsibility for payment • Request payment at point of service • Simplify bills to improve patient understanding • Provide financial credit to patients from a 3rd party in a pilot program 28
  • 29. Cash Flow Capex was $179mm Adjusted operating cash flow $82mm YTD $93mm in Q3’07 Q3’07 cash flow impacted by: $14mm insurance premiums (do not recur in Q4’07) $12mm receipt from Philadelphia HMO sale $123mm in interest payments Compared to $82mm in Q4’07 $43mm net favorable impact from above 3 items Q4’07 compared to Q3’07 Additional working capital initiatives expected to impact Q4’07 29
  • 30. 2007 Cash Walk Forward ($ in millions) Beginning Cash (September 30, 2007) 655 Income Tax Payments (8) Sale of Facilities and Property 13 Acquisition Activity (11) Remaining Interest, net (72) DOJ Principal Payment (24) Working Capital Including 120 - 150 – AP build-up and terms – Normal accruals – A/R days reduction EBITDA (Q4’07) 140 - 190 Stock Compensation Expense & Other 2 -12 CapEx (Q4’07) (285) – (235) Ending Cash (December 31, 2007) 530 - 670 30
  • 31. Capital Expenditures Per Bed $54,249 $48,055 $46,515 $45,876 $45,423 $44,217 $42,695 $42,298 $42,966 $41,627 $41,528 Tenet’s 3-year Tenet’s 3-year $38,652 ’05-’07 average is $37,993 $36,722 ’05-’07 average is $35,373 $36,026 $34,279 $41,528 per bed $41,528 per bed Tenet HCA Triad Tenet’s t. 02 03 04 05 06 3-year Avg. es 20 20 20 20 20 ’05-’07 07 20 * 55 core hospitals from 2002 – 2007. * 2007 capex estimate of $700mm (middle of range of $675 - $725mm) includes approximately $150 million carried over from prior 2006 commitment of $800 million. 31
  • 32. 2007 Outlook (1) Actual Outlook ($ millions) YTD Q3’07 Q4’07 2007 9/30/07 Revenue (Growth %) (2) 4.0 7.0 3.0 – 4.0 3.5 – 4.5 Admissions (Growth %) (2) (1.4) (0.8) (0.5) – 0.5 (1.2) – (0.9) Outpatient visits (Growth %) (2) (2.1) (1.4) 0 – 1.0 (1.6) – (1.4) Adjusted EBITDA (3) 535 177 140 – 190 675 – 725 Pretax Income (Loss) (3) (16) (9) (58) – (8) (75) – (25) Net Loss (4) (14) (14) (52) – (2) (66) – (16) EPS (4) (0.02) (0.03) (0.08) – (0.01) (0.10) – (0.03) Cash from Ops (3) 82 93 198 – 278 280 – 360 Capital Spending 440 179 235 – 285 675 – 725 Cash (Period End) 655 655 530 – 670 530 – 670 (1) In $ millions, except per share amounts. (2) Same hospital. (3) Adjusted EBITDA excludes charges/payments for impairment, restructuring and litigation. (4) Excludes the change in the federal income tax valuation allowance and first quarter 2007 FIN 48 tax gain and assumes a normalized tax rate of 37.5%. Note: For reconciliation of net loss to adjusted EBITDA see table #3 in our third quarter earnings release. 32
  • 33. Summary Results could be bumpy but positive trends developing Progress on volumes, pricing and costs Focused on cash and return on invested capital Bad debt expense increase mitigated by aggressive offsetting actions 33
  • 34. Appendix: Reconciliation of 2007 Outlook net loss to adjusted EBITDA ($ in millions) Low High Net loss $(76) $(26) Less: Loss from discontinued operations, net of tax (1) (51) (51) Income (Loss) from continuing operations (25) 25 Income tax benefit (2) 75 75 Loss from continuing operations, before income taxes (100) (50) Interest expense, net (380) (380) Operating income 280 330 Litigation benefit (1) (1) (1) Impairment of long-lived assets and goodwill and restructuring (24) (24) charges (1) Depreciation and amortization (370) (370) Adjusted EBITDA $675 $725 (1) Represents the loss from discontinued operations for the nine months ended September 30, 2007, litigation and related costs and impairment and restructuring charges. Management is not providing a forecast of these items for the remainder of 2007. (2) Includes a favorable income tax adjustment of $93 million in Q1 2007, required under the new FASB pronouncement FIN 48. 34
  • 35. 2009 EBITDA Walk-Forward - - Assumptions (1) ($mm) Walk-forward starting point 700 Price and cost inflation/market adjustment 140 -145 Length of stay reduction 15 – 30 Hospital/function-specific productivity 100 Other upside initiatives (2) 30+ 1.5% annual volume growth from 2007 base (3) 105 Provision for risk (0 –100) Implied EBITDA range in 2009 (rounded) 1,000 – 1,100 Risks and opportunities currently projected to be realized: Georgia and Florida Medicaid (4) (60) (1) Walk-forward to $1.0 to $1.1 billion is as discussed on second quarter conference call (8/6/07). Planning cycle for 2008 is currently in progress and Outlook is expected to be provided during the year end conference call in late February 2008. (2) Reflects the continuation of 2007 upside initiatives. (3) Assumes variable margin of 40% on increased volume in adjusted admissions (4) Represents significant identified changes absorbing the zero to $100 million provision for risk allowed for in the walk-forward above. There are other risks and opportunities which will be considered in 2008 planning, and which are expected to be net favorable. 35 NOTE: Refer to Tenet’s 2006 Form 10-K for other risk factors